Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00678249 · ClinicalTrials.gov registry record · NA
Pivotal Study for the FLAIR Endovascular Stent Graft
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 227
- Enrollment target
NCT00678249 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 227 participants.
The verdict
NCT00678249, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 227 participants
- Enrollment target
Study Summary
This study compared the FLAIR™ Endovascular Stent Graft to balloon angioplasty in patients with stenoses at the venous anastomosis of a synthetic AV access graft.
Interventions
- DEVICE FLAIR Endovascular Stent Graft
- PROCEDURE PTA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2001-01 |
| Est. Completion | 2004-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00678249
The ClinicalTrials.gov registry entry for NCT00678249 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FLAIR Endovascular Stent Graft is the first listed.
NCT00678249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00678249 about?
NCT00678249 is a clinical study titled "Pivotal Study for the FLAIR Endovascular Stent Graft". This study compared the FLAIR™ Endovascular Stent Graft to balloon angioplasty in patients with stenoses at the venous anastomosis of a synthetic AV access graft.
What is the current status of trial NCT00678249?
This trial is currently completed. It is a NA study. The enrollment target is 227 participants. The study started on 2001-01. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00678249?
The interventions under investigation include: FLAIR Endovascular Stent Graft (DEVICE), PTA (PROCEDURE).
Who is sponsoring clinical trial NCT00678249?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.